May 8, 2018 – The U.S. Preventive Services Task Force released today a final recommendation statement on screening for prostate cancer. Based on a review of the evidence, the Task Force recommends that men aged 55 to 69 years make an individual decision about whether to be screened after a conversation with their clinician about the potential benefits and harms. For men 70 years and older, the potential benefits do not outweigh the expected harms, and these men should not be routinely screened for prostate cancer. To view the recommendation and the evidence on which it is based, please go here. The final recommendation statement can also be found in the May 8 online issue of JAMA.
In addition to posting the final materials, the Task Force has developed answers to frequently asked questions, a video, and an infographic to help health care professionals, stakeholders, and the public understand and communicate about these recommendations.
